Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000

Objective: Determine the effect of scalp infiltration on postoperative craniotomy pain with 0.5% bupivacaine with adrenaline 1:400,000. Material and Method: A prospective randomized double blind control trial was conducted on 50 patients (18-65 years), who were ASA physical status I to III, and sche...

Full description

Saved in:
Bibliographic Details
Main Authors: Saringcarinkul A., Boonsri S.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-55249083037&partnerID=40&md5=5a9456f2cf06544f1741574ff4a75024
http://www.ncbi.nlm.nih.gov/pubmed/18972894
http://cmuir.cmu.ac.th/handle/6653943832/2359
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-2359
record_format dspace
spelling th-cmuir.6653943832-23592014-08-30T02:00:45Z Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000 Saringcarinkul A. Boonsri S. Objective: Determine the effect of scalp infiltration on postoperative craniotomy pain with 0.5% bupivacaine with adrenaline 1:400,000. Material and Method: A prospective randomized double blind control trial was conducted on 50 patients (18-65 years), who were ASA physical status I to III, and scheduled for elective intracranial surgery at Maharaj Nakorn Chiang Mai Hospital, Thailand between October 2006 and December 2007. The patients received wound infiltration before skin closure by either 0.5% bupivacaine with adrenaline 1:400,000 (group B), or normal saline with adrenaline 1:400,000 (group S). Results: The median pain score in the first 12 hours trended to be lower in the bupivacaine group than in the control, but the differences were not statistically significant apart from the score in the first hour (median pain score = 2, IQR = 3; p = 0.031). There were more pain-free patients in the bupivacaine group than in the control group at all time intervals during the first 12 hours. However, the difference was significant in the first hour (7 vs. 1; p = 0.034). Although the median (range) time interval between the end of surgery and first administration of tramadol was longer in the bupivacaine group, when compared to the control group, it was not statistically significant. Conclusion: Surgical wound infiltration, before skin closure, with 0.5% bupivacaine with adrenaline decreased the incidence and severity of postoperative pain in patients undergoing supratentorial craniotomy, but only for the first hour after surgery. 2014-08-30T02:00:45Z 2014-08-30T02:00:45Z 2008 Article 01252208 18972894 JMTHB http://www.scopus.com/inward/record.url?eid=2-s2.0-55249083037&partnerID=40&md5=5a9456f2cf06544f1741574ff4a75024 http://www.ncbi.nlm.nih.gov/pubmed/18972894 http://cmuir.cmu.ac.th/handle/6653943832/2359 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Objective: Determine the effect of scalp infiltration on postoperative craniotomy pain with 0.5% bupivacaine with adrenaline 1:400,000. Material and Method: A prospective randomized double blind control trial was conducted on 50 patients (18-65 years), who were ASA physical status I to III, and scheduled for elective intracranial surgery at Maharaj Nakorn Chiang Mai Hospital, Thailand between October 2006 and December 2007. The patients received wound infiltration before skin closure by either 0.5% bupivacaine with adrenaline 1:400,000 (group B), or normal saline with adrenaline 1:400,000 (group S). Results: The median pain score in the first 12 hours trended to be lower in the bupivacaine group than in the control, but the differences were not statistically significant apart from the score in the first hour (median pain score = 2, IQR = 3; p = 0.031). There were more pain-free patients in the bupivacaine group than in the control group at all time intervals during the first 12 hours. However, the difference was significant in the first hour (7 vs. 1; p = 0.034). Although the median (range) time interval between the end of surgery and first administration of tramadol was longer in the bupivacaine group, when compared to the control group, it was not statistically significant. Conclusion: Surgical wound infiltration, before skin closure, with 0.5% bupivacaine with adrenaline decreased the incidence and severity of postoperative pain in patients undergoing supratentorial craniotomy, but only for the first hour after surgery.
format Article
author Saringcarinkul A.
Boonsri S.
spellingShingle Saringcarinkul A.
Boonsri S.
Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
author_facet Saringcarinkul A.
Boonsri S.
author_sort Saringcarinkul A.
title Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
title_short Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
title_full Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
title_fullStr Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
title_full_unstemmed Effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
title_sort effect of scalp infiltration on postoperative pain relief in elective supratentorial craniotomy with 0.5% bupivacaine with adrenaline 1:400,000
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-55249083037&partnerID=40&md5=5a9456f2cf06544f1741574ff4a75024
http://www.ncbi.nlm.nih.gov/pubmed/18972894
http://cmuir.cmu.ac.th/handle/6653943832/2359
_version_ 1681419843871440896